Explore more topics
SEC reporting owner

TAKEDA PHARMACEUTICAL CO LTD SEC insider disclosures

Explore TAKEDA PHARMACEUTICAL CO LTD's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-13T06:40:31.983Z

Reporting owner CIK
0001395064
Issuers
13
Coverage
verified
Jump to a section

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Scroll sideways to compare all columns. Select a heading to sort.

Molecular Templates, Inc.0001183765MTEMNoNo
Myovant Sciences Ltd.0001679082MYOVNoNo
Cortexyme, Inc.0001662774CRTXNoNo
Mirum Pharmaceuticals, Inc.0001759425MIRMNoNo
Phathom Pharmaceuticals, Inc.0001783183PHATNoNo
BiomX Inc.0001739174PHGENoNo
Ovid Therapeutics Inc.0001636651OVIDNoNo
Translate Bio, Inc.0001693415TBIONoNo
Day One Biopharmaceuticals, Inc.0001845337DAWNNoNo
Theseus Pharmaceuticals, Inc.0001745020THRXNoNo
Xilio Therapeutics, Inc.0001840233XLONoNo
Calithera Biosciences, Inc.0001496671CALANoNo
HilleVax, Inc.0001888012HLVXNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.